The following research will be presented during the 2025 US HUPO (US Human Proteome Organization) Conference, held February 22nd - 26th in Philadelphia, PA:
“Measuring Methyltransferase Activity using Cell-Deliverable Affinity-Based Peptide Probes (cAfBPs)” will be presented by Loran Gliford on Tuesday, February 25th, 4:30-6:00 PM.
Prof. Pratt presented at the 10th annual AACR Special Conference on Pancreatic Cancer in the plenary session on Early Detection and Interception of Precursor Lesions. Her talk was entitled “Multimodal tools for noninvasive cancer monitoring.
Prof. Pratt will co-chair the BMES Annual Meeting Cancer Technologies Track with Prof. Madeleine Oudin. The meeting will take place in Baltimore, Maryland, Oct 23-26 2024.
The following projects will be presented during the 2023 BMES Annual Meeting, held October 11th - 14th in Seattle, WA:
“Optimization and Expansion of Digital PCR Multiplexing for Rare Mutation Detection” presented by Colin Skeen in the Imaging Strategies in Cancer Detection, Diagnosis, and Prognosis session on October 13th from 8:30-8:45 AM.
Prof. Pratt will be discussion leader for the “Clinical Applications Toward Personalized Detection and Therapy” session at the Physical Science of Cancer Gordon Research Conference. The conference will be held Feb 5-10 at the Grand Galvez in Galveston, TX.
Prof. Pratt will co-chair the BMES Annual Meeting Cancer Technologies Track Session entitled “Microengineered Models of Tumor-Stromal Interactions.” The session will be held on October 15th from 3 - 4:30 pm in room 214D at the Henry B Gonzales Convention Center.